News

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, months before they were abruptly fired by U.S. Health Secretary Robert F ...
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna shares were up 5.9% on Wednesday, while Pfizer was up 1%. GSK’s American ...
The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...
A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...
Key Takeaways High-risk adults as young as 50 are now eligible for the RSV vaccineThe update follows advice from now-deposed ...
The American College of Obstetricians and Gynecologists (ACOG) plans to develop and release recommendations on maternal immunizations, including COVID-19 vaccination, alongside the Center for ...
The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed the use of respiratory syncytial virus (RSV) vaccines for adults aged 50 to ...